510(k) K240217
K240217 is an FDA 510(k) premarket notification submitted by Roche Molecular Systems, Inc. for the device "cobas® liat CT/NG nucleic acid test". The FDA issued a decision of Substantially Equivalent on Jan 17, 2025. The device falls under product code QEP (Nucleic Acid Detection System For Non-Viral Microorganism(S) Causing Sexually Transmitted Infections), a Class II device regulated under 21 CFR 866.3393. Roche Molecular Systems, Inc. has 54 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Jan 17, 2025
- Date Received
- Jan 26, 2024
- Clearance Type
- Dual Track
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Nucleic Acid Detection System For Non-Viral Microorganism(S) Causing Sexually Transmitted Infections
- Device Class
- Class II
- Regulation Number
- 866.3393
- Review Panel
- MI
- Submission Type
- 510(k)
A device to detect nucleic acids from non-viral microorganism(s) causing sexually transmitted infections is an in vitro diagnostic device intended for the detection and identification of nucleic acids from non-viral microorganism(s) in clinical specimens collected from patients suspected of sexually transmitted infections. The device is intended to aid in the diagnosis of non-viral sexually transmitted infections in conjunction with other clinical and laboratory data.
Need the full FDA record for Roche Molecular Systems, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.